Tag #Obesity

Showing 109 to 120 of 176 results

foxnews.com

🌐 85% Global Worthiness

Jan 28, 01:08

Kennedy's HHS Nomination Hearing Highlights Urgent US Health Crisis

Robert F. Kennedy Jr.'s upcoming confirmation hearing for HHS Secretary on January 29th centers on his "Make America Healthy Again" movement, aiming to combat the U.S.'s health crisis through improved nutrition and reduced environmental toxins, as supported by Fox News medical analyst Dr. Marc Siege...

Kennedy's HHS Nomination Hearing Highlights Urgent US Health Crisis

Robert F. Kennedy Jr.'s upcoming confirmation hearing for HHS Secretary on January 29th centers on his "Make America Healthy Again" movement, aiming to combat the U.S.'s health crisis through improved nutrition and reduced environmental toxins, as supported by Fox News medical analyst Dr. Marc Siege...

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the long-term societal and economic consequences of successfully implementing the MAHA movement's proposed changes, and what potential obstacles could hinder its progress?

The long-term impact of Kennedy's potential appointment hinges on the success of the MAHA movement. Its focus on nutrition, environmental toxins, and corporate influence suggests a potential shift toward preventative healthcare. The economic implications are significant, as improved public health could lead to lower healthcare costs associated with obesity-related diseases.

bbc.com

🌐 85% Global Worthiness

Jan 28, 10:06

Kennedy-Oz Clash on Weight-Loss Drug Coverage Looms

The conflicting views of Robert F. Kennedy Jr. and Mehmet Oz on the Trump administration's policy regarding Medicare and Medicaid coverage of costly new weight-loss drugs create uncertainty, impacting millions' access to potentially life-changing medication.

Kennedy-Oz Clash on Weight-Loss Drug Coverage Looms

The conflicting views of Robert F. Kennedy Jr. and Mehmet Oz on the Trump administration's policy regarding Medicare and Medicaid coverage of costly new weight-loss drugs create uncertainty, impacting millions' access to potentially life-changing medication.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate impacts of the high cost and limited insurance coverage of new weight-loss drugs on patients' access to treatment and overall health outcomes?

The high cost of new weight-loss drugs, averaging \$1,000 per month, and limited insurance coverage create significant access barriers for many patients. Dr. Mollie Cecil's experience exemplifies this, highlighting how loss of coverage led to weight regain. This impacts patient health and raises concerns about equitable access to potentially life-changing medication.

bbc.com

🌐 75% Global Worthiness

Jan 27, 07:09

NPA warns of weight-loss jab safety risks from online sales

The National Pharmacy Association (NPA) warns of patient safety risks from online sales of weight-loss jabs, urging for stricter regulations and mandatory 20-minute consultations to prevent misuse, particularly in individuals with eating disorders or low body weight. Hundreds of thousands use online...

NPA warns of weight-loss jab safety risks from online sales

The National Pharmacy Association (NPA) warns of patient safety risks from online sales of weight-loss jabs, urging for stricter regulations and mandatory 20-minute consultations to prevent misuse, particularly in individuals with eating disorders or low body weight. Hundreds of thousands use online...

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate patient safety concerns raised by the NPA regarding online sales of weight-loss injections?

The National Pharmacy Association (NPA) warns of patient safety risks from online sales of weight-loss jabs like Wegovy and Mounjaro, citing inadequate consultations and potential misuse in individuals with eating disorders or low body weight. They advocate for mandatory 20-minute consultations to ensure safe prescribing practices. Hundreds of thousands obtain prescriptions privately through online pharmacies.

foxnews.com

🌐 85% Global Worthiness

Jan 23, 13:10

GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study

A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.

GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study

A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the mechanisms of action of GLP-1 drugs explain their observed effects on both cognitive function and addiction?

The study, published in Nature, establishes widespread associations between GLP-1 agonists and various health outcomes. These drugs impact brain receptors related to impulse control, reducing cravings. Weight loss and decreased brain inflammation are suggested as mechanisms for improved cognitive health.

smh.com.au

🌐 85% Global Worthiness

Jan 21, 04:08

GLP-1 Weight-Loss Drugs: Significant Health Benefits and Risks Revealed

A study of over 2.4 million people found that GLP-1 weight-loss medications reduced the risk of 42 health conditions, including cardiac arrest and Alzheimer's disease, by reducing inflammation and improving impulse control, but increased risks of gastrointestinal issues were also observed.

GLP-1 Weight-Loss Drugs: Significant Health Benefits and Risks Revealed

A study of over 2.4 million people found that GLP-1 weight-loss medications reduced the risk of 42 health conditions, including cardiac arrest and Alzheimer's disease, by reducing inflammation and improving impulse control, but increased risks of gastrointestinal issues were also observed.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the most significant health benefits and risks associated with GLP-1 weight-loss medications, according to this large-scale study?

A major study analyzing 2.4 million health records revealed that GLP-1 weight-loss medications, such as Ozempic and Wegovy, reduced the risk of over 40 health conditions, including cardiac arrest (22%), pneumonia (16%), and Alzheimer's (12%). However, increased risks of nausea, headaches, and abdominal pain were also observed.

dailymail.co.uk

🌐 85% Global Worthiness

Jan 20, 04:08

Intramuscular Fat: A Novel Risk Factor for Heart Disease

A study of 669 individuals found that higher levels of intramuscular fat, irrespective of BMI, significantly increase the risk of heart attack and heart failure, highlighting a previously unrecognized risk factor for cardiovascular disease.

Intramuscular Fat: A Novel Risk Factor for Heart Disease

A study of 669 individuals found that higher levels of intramuscular fat, irrespective of BMI, significantly increase the risk of heart attack and heart failure, highlighting a previously unrecognized risk factor for cardiovascular disease.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the underlying mechanisms by which intramuscular fat contributes to cardiovascular disease?

This research analyzed 669 individuals' CT scans, tracking their health for six years. Higher intramuscular fat correlated with increased heart vessel damage and subsequent cardiac events. This challenges the reliance on BMI as a sole indicator of cardiovascular risk, highlighting a previously under-recognized factor.

dailymail.co.uk

🌐 85% Global Worthiness

Jan 28, 07:10

Fat Cell Memory Explains Weight Regain After Dieting

A Nature study reveals that fat cells 'remember' being fat, making weight loss difficult; 90% of dieters regain weight due to epigenetic changes in fat cells that persist even after weight loss, highlighting the need for long-term lifestyle changes for sustainable weight management.

Fat Cell Memory Explains Weight Regain After Dieting

A Nature study reveals that fat cells 'remember' being fat, making weight loss difficult; 90% of dieters regain weight due to epigenetic changes in fat cells that persist even after weight loss, highlighting the need for long-term lifestyle changes for sustainable weight management.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What biological mechanism explains the high rate of weight regain after dieting, and what are its implications for long-term weight management?

A recent study reveals that fat cells possess a "memory," retaining their ability to absorb fat even after weight loss, explaining why 90% of dieters regain weight. This "fat cell memory" is due to epigenetic changes affecting how genes control fat absorption, making weight maintenance difficult.

nos.nl

🌐 85% Global Worthiness

Jan 27, 22:08

Soaring Demand for Expensive Weight-Loss Drugs in the Netherlands

The number of Dutch citizens purchasing costly new weight-loss drugs increased dramatically from 2000 prescriptions in 2022 to 109,000 in 2023, raising concerns about accessibility and the strain on the healthcare system due to high costs and potential exacerbation of health inequalities.

Soaring Demand for Expensive Weight-Loss Drugs in the Netherlands

The number of Dutch citizens purchasing costly new weight-loss drugs increased dramatically from 2000 prescriptions in 2022 to 109,000 in 2023, raising concerns about accessibility and the strain on the healthcare system due to high costs and potential exacerbation of health inequalities.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the high cost of these medications contribute to existing health inequalities?

The surge in demand is driven by increased accessibility of Ozempic and similar medications, which suppress hunger. However, these drugs are expensive (Mounjaro costs €410 per month), unaffordable for many, exacerbating existing health inequalities. The high cost also raises concerns about the financial burden on the healthcare system if the government were to cover these treatments.

cnn.com

🌐 85% Global Worthiness

Jan 24, 16:09

Revised Obesity Definition Emphasizes Body Fat Impact, Not Just BMI

A new definition of obesity, published in The Lancet Diabetes & Endocrinology, proposes using BMI as an initial screen, but factors in waist circumference and other measures of body fat to assess how excess fat affects the body, potentially shifting clinical care for 890 million adults worldwide.

Revised Obesity Definition Emphasizes Body Fat Impact, Not Just BMI

A new definition of obesity, published in The Lancet Diabetes & Endocrinology, proposes using BMI as an initial screen, but factors in waist circumference and other measures of body fat to assess how excess fat affects the body, potentially shifting clinical care for 890 million adults worldwide.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the limitations of using BMI as the sole measure for defining obesity, and how does the proposed revised definition address these limitations?

Body mass index (BMI) is calculated by dividing weight in kilograms by height in meters squared. Criticisms include its failure to distinguish between muscle and fat mass, leading to misclassifications, and inconsistent accuracy across different racial and ethnic groups. The American Medical Association has also noted BMI's limitations.

it.euronews.com

🌐 85% Global Worthiness

Jan 21, 01:09

Weight-Loss Drugs Show Reduced Alzheimer's Risk, But Increased Gastrointestinal Issues

A study of over two million US diabetic patients found that GLP-1 receptor agonist weight-loss drugs like Wegovy and Ozempic reduced the risk of Alzheimer's by 12%, drug/alcohol dependence, and some blood clotting issues, but increased risks of gastrointestinal problems, low blood pressure, and kidn...

Weight-Loss Drugs Show Reduced Alzheimer's Risk, But Increased Gastrointestinal Issues

A study of over two million US diabetic patients found that GLP-1 receptor agonist weight-loss drugs like Wegovy and Ozempic reduced the risk of Alzheimer's by 12%, drug/alcohol dependence, and some blood clotting issues, but increased risks of gastrointestinal problems, low blood pressure, and kidn...

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the significant health risks and benefits associated with GLP-1 receptor agonist weight-loss drugs based on the study of over two million patients?

A large-scale study of over two million US diabetic patients revealed that GLP-1 receptor agonist weight-loss drugs, like Wegovy and Ozempic, are associated with a reduced risk of various health issues, including Alzheimer's disease (12% reduction), drug/alcohol dependence, and certain blood clotting problems. However, these drugs also showed increased risks of gastrointestinal problems, low blood pressure, and kidney stones.

fr.euronews.com

🌐 85% Global Worthiness

Jan 21, 10:09

Weight-Loss Drugs Show Promise in Treating Multiple Diseases, but Risks Remain

A Nature Medicine study shows weight-loss drugs like Wegovy and Ozempic effectively treat various diseases by reducing obesity and inflammation, potentially lowering Alzheimer's risk by 12%, but also carry risks of gastrointestinal issues, hypotension, and kidney problems.

Weight-Loss Drugs Show Promise in Treating Multiple Diseases, but Risks Remain

A Nature Medicine study shows weight-loss drugs like Wegovy and Ozempic effectively treat various diseases by reducing obesity and inflammation, potentially lowering Alzheimer's risk by 12%, but also carry risks of gastrointestinal issues, hypotension, and kidney problems.

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the findings of this study challenge previous understandings of obesity and its treatment?

The study highlights the dual mechanism of GLP-1 receptor agonists: reducing obesity, a risk factor for many diseases, and directly decreasing inflammation, which affects brain reward signals, impulse control, and blood circulation. This broad impact suggests potential benefits across several health areas, including neurocognitive disorders.

elpais.com

🌐 85% Global Worthiness

Jan 20, 04:08

Ultra-Processed Food Regulation Fails: Systemic Change Needed

A study of 417 measures from 105 countries reveals that current regulations, focusing primarily on consumer behavior, have failed to curb the rise of ultra-processed foods, which comprise 70% of the average American diet and are linked to serious health problems; the authors call for systemic change...

Ultra-Processed Food Regulation Fails: Systemic Change Needed

A study of 417 measures from 105 countries reveals that current regulations, focusing primarily on consumer behavior, have failed to curb the rise of ultra-processed foods, which comprise 70% of the average American diet and are linked to serious health problems; the authors call for systemic change...

Progress

44% Bias Score

ShareSaveArticle

Zero Hunger

12345678

Previous 1 of 8 Next

What are the primary reasons for the continued rise in ultra-processed food consumption despite various government interventions?

Processed foods, including popular items like nuggets and pizza, are increasingly linked to health issues such as obesity and diabetes. A 2019 study found they constitute 70% of the average American diet, and their consumption has risen explosively in recent decades. Despite various countries implementing measures to limit consumption, these efforts have been largely ineffective.

Showing 109 to 120 of 176 results